Eledon Pharmaceuticals, Inc.
ELDN
$2.62
$0.0451.75%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.64M | 19.58M | 18.61M | 15.12M | 14.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 87.90M | 77.67M | 70.58M | 56.22M | 46.91M |
| Operating Income | -87.90M | -77.67M | -70.58M | -56.22M | -46.91M |
| Income Before Tax | 15.07M | -18.62M | -35.75M | -21.67M | -108.54M |
| Income Tax Expenses | 431.00K | 431.00K | 431.00K | -- | -- |
| Earnings from Continuing Operations | 14.64 | -19.05 | -36.18 | -21.67 | -108.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.64M | -19.05M | -36.18M | -21.67M | -108.54M |
| EBIT | -87.90M | -77.67M | -70.58M | -56.22M | -46.91M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.22 | -0.70 | -1.40 | -1.80 | -3.18 |
| Normalized Basic EPS | 0.39 | -0.19 | -0.63 | -0.86 | -1.99 |
| EPS Diluted | -1.14 | -2.06 | -2.76 | -3.17 | -3.18 |
| Normalized Diluted EPS | 0.33 | -0.24 | -0.68 | -0.92 | -1.99 |
| Average Basic Shares Outstanding | 276.07M | 241.20M | 194.06M | 154.25M | 132.28M |
| Average Diluted Shares Outstanding | 279.61M | 244.73M | 197.59M | 157.78M | 132.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |